UAE generic drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of surging demand for affordable healthcare services. Increasing demand for the medicines and drugs to the chronic patient exposed to prolonged medication further demand generic drugs over branded drugs, thereby driving the growth of the UAE generic drugs market in the upcoming five years. Easier FDA approvals to generic drugs also support the growth of the UAE generic drugs market in the next five years.

Generic drugs are medicines that has exactly same active ingredients, same safety standards, are equally effective, and are of high quality as much as the branded drugs but are much cheaper than the branded drugs. Dosage, therapeutic activity, administration, and formulation of the generic drug is exactly same as the branded drugs.

The major difference between the two is the cost of drugs and inert ingredients that give the drug its color, shape or taste. Once the patent of the branded drug expires, generic drug manufacturers duplicate the chemical formulas of the branded drug to manufacture generic drug. Manufacturing and patient use does not require the extensive clinical trials to prove safety and its efficiency.

If the molecule formula and safety standards are followed during the manufacturing the drug is soon released in the market thus making the manufacturing process cost-efficient thus the low prices of the drugs. Examples of generic drugs include “metformin”. Metformin is a generic drug for the branded drug, “Glucophage” which is used for diabetes. Similarly, “metoprolol” is used for hypertension instead of “Lopressor”.

Growing Pharmaceutical Industry Promises Market Growth

UAE pharmaceutical industry is expanding rapidly due to surging demands for pharmaceutical products, increasing imports of pharmaceuticals to satisfy the surging demands as well as increased manufacturing of generic drugs by local manufacturers that further drives the growth of the UAE generic drugs market in the upcoming five years. According to government sources, the demand for pharmaceuticals in Dubai region alone would exceed 5 million, further expansion is also expected due to overall increasing population all over the country.

Pharmaceutical manufacturing landscape in UAE has been dominated by generic drug manufacturers and contract manufacturing organizations (for medical therapeutics). Although global giants are penetrating the market large number of manufacturing units for the branded drugs are not yet flooding the country. The market players have although made Dubai as a regional hub due to favorable tax environment, well-developed infrastructure and bustling labor force.

Increasing Chronic Diseases Instances Drive Market Growth

Increasing instances of chronic diseases like cardiovascular diseases, cancer, diabetes, etc. further drives the growth of the UAE generic drugs market in the upcoming five years. Due to cardiovascular diseases over 40% of deaths are caused every year in the UAE.

Demands for the drugs for prolonged period due to chronic conditions of the diseases further supports the growing demand for the generic drugs to reduce the treatment costs of the diseases. By the year 2021, the country had 6176 generic drugs being manufactured in that costed less than 60% than the branded medicines making healthcare much affordable for the common population.

The country had 16 factories in medical and pharmaceutical industry and three others for intravenous fluids, laboratories, and medical supplies in 2021 and the count is increasing further. The government is also investing in outpatient healthcare service that aid the market, the value of UAE outpatient healthcare expenditure in 2020 was USD7.41 billion.

Click here to download the sample

Market Segmentation

The UAE generic drugs market is segmented by type, mode of drug delivery, form, source, distribution channel, application, competitional landscape, and regional distribution.

Based on type, the market is differentiated between small molecule generics and biosimilars. By mode of drug delivery, the market is further segmented into oral, topical, parenteral, and others. Form based market is fragmented into tablet, capsule, injection, and others. By source, the market is differentiated between in house and contract manufacturing organizations.

Based on distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. By application, market segments are defined into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi region, Dubai region, Sharjah region and the rest of UAE.  

Company Profile

Gulf Pharmaceutical Industries (Julphar), Sanofi UAE, Sun Pharma Global FZE, Abbott Laboratories SA, Eli Lilly & Company UAE, Mylan UAE, GlaxoSmithKline & Neopharma, among others is a partial list of major market players of the companies responsible for the growth of UAE generic drugs market.



Base Year


Historical Data

2017 – 2020

Estimated Year


Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Type

·         Mode of Drug Delivery

·         Form

·         Source

·         Distribution Channel

·         Application

Regional scope

Abu Dhabi region, Dubai region, Sharjah region and the rest of UAE.

Key companies profiled

Gulf Pharmaceutical Industries (Julphar), Sanofi UAE, Sun Pharma Global FZE, Abbott Laboratories SA, Eli Lilly & Company UAE, Mylan UAE, GlaxoSmithKline & Neopharma

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, UAE generic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • UAE Generic Drugs Market, By Type:
    • Small Molecule Generics
    • Biosimilars
  • UAE Generic Drugs Market, By Mode of Drug Delivery:
    • Oral
    • Topical
    • Parenteral
    • Others
  • UAE Generic Drugs Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Others
  • UAE Generic Drugs Market, By Source:
    • In House
    • Contract Manufacturing Organizations
  • UAE Generic Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • UAE Generic Drugs Market, By Application:
    • Cardiovascular Diseases
    • Diabetes
    • Neurology
    • Oncology
    • Anti-Inflammatory Diseases
    • Others
  • UAE Generic Drugs Market, By Region:

o   Abu Dhabi region

o   Dubai region

o   Sharjah region

o   Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE generic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
UAE Generic Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on UAE Generic Drugs Market

4.    Voice of Customer

5.    Executive Summary

6.    UAE Generic Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Small Molecule Generics v/s Biosimilars)

6.2.2.     By Mode of Drug Delivery (Oral, Topical, Parenteral, Others)

6.2.3.     By Form (Tablet, Capsule, Injection, Others)

6.2.4.     By Source (In House v/s Contract Manufacturing Organizations)

6.2.5.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

6.2.6.     By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)

6.2.7.     By Company (2021)

6.2.8.     By Region

6.3.  Product Market Map

7.    UAE Small Molecule Generic Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Mode of Drug Delivery

7.2.2.     By Form

7.2.3.     By Source

7.2.4.     By Distribution Channel

7.2.5.     By Application

8.    UAE Biosimilar Generic Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Mode of Drug Delivery

8.2.2.     By Form

8.2.3.     By Source

8.2.4.     By Distribution Channel

8.2.5.     By Application

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  UAE Economic Profile

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Company Profiles

13.2.1.  Gulf Pharmaceutical Industries (Julphar)

13.2.2.  Sanofi UAE

13.2.3.  Sun Pharma Global FZE

13.2.4.  Abbott Laboratories SA

13.2.5.  Eli Lilly & Company UAE

13.2.6.  Mylan UAE

13.2.7.  GlaxoSmithKline & Neopharma

14.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]